Lilly’s long-acting insulin wins NICE blessing ahead of potential UK approval
For patients living with Type 2 diabetes in the United Kingdom, a more convenient treatment option may be…
Who Really Benefits from Britain’s Medical Cannabis System?
Written for Business of Cannabis by Saxon Coop, Founder & CEO of Toke. In March, The Times reported…
Acclaim names UK boss as it expands into US market
Acclaim has expanded in the UK with the appointment of Paul Thomas as Senior Vice President, EMEA, as…